Financhill
Back

ACADIA Pharmaceuticals 10K Form

Sell
35

ACAD
ACADIA Pharmaceuticals

Last Price:
18.09
Seasonality Move:
7.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive ACAD News And Ratings

See the #1 stock for the next 7 days that we like better than ACAD

ACAD Financial Statistics

Sales & Book Value

Annual Sales: $726.44M
Cash Flow: $85.39M
Price / Cash Flow: 0
Annual Sales: $2.62
Price / Book: 6.95

Profitability

EPS (TTM): -0.38000
Net Income (TTM): $-61.29M
Gross Margin: $684.8M
Return on Equity: -15.6%
Return on Assets: -9.38%

ACADIA Pharmaceuticals Earnings Forecast

Key ACADIA Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 19 years for ACAD is 94.27%.
  • The Selling, General & Administrative Expenses for ACAD have been equal to 55.97% of Gross Profit Margin.
  • The Research & Development expenses have been 48.40% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ACAD is -8.44% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 11 years.

ACADIA Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ACAD
CUSIP: 004225
Website: acadia.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.42
Quick Ratio: 2.13

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 14.25

ACAD Technical Analysis vs Fundamental Analysis

Sell
35
ACADIA Pharmaceuticals (ACAD) is a Sell

Is ACADIA Pharmaceuticals a Buy or a Sell?